“In the present study, the … a range of recently developed GABAB receptor antagonists (phaclofen, 2-hydroxysaclofen, beta-phenyl-beta-alanine, CGP 35348) and the GABAB receptor agonist baclofen, … for their ability to block the locomotor stimulation induced by a low dose of ethanol administered IP to ….75 g/kg).”